Price Chart

Profile

TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE. The company was founded by Yigong Shi, John M. Gill and Mark A. McKinlay in July 2001 and is headquartered in Malvern, PA.
URL N/A
Investor Relations URL http://ir.tetralogicpharma.com/
HQ State/Province Pennsylvania
Sector Health Care
Industry Biotechnology
Next Earnings Release N/A
Last Earnings Release Feb. 25, 2016
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE. The company was founded by Yigong Shi, John M. Gill and Mark A. McKinlay in July 2001 and is headquartered in Malvern, PA.
URL N/A
Investor Relations URL http://ir.tetralogicpharma.com/
HQ State/Province Pennsylvania
Sector Health Care
Industry Biotechnology
Next Earnings Release N/A
Last Earnings Release Feb. 25, 2016
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A